Gene Expression of the Tumour Suppressor LKB1 Is Mediated by Sp1, NF-Y and FOXO Transcription Factors
暂无分享,去创建一个
[1] V. McKusick,et al. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. , 1949, The New England journal of medicine.
[2] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[3] P Chambon,et al. Promoter sequences of eukaryotic protein-coding genes. , 1980, Science.
[4] C. Der,et al. Human cell hybrids: analysis of transformation and tumorigenicity. , 1982, Science.
[5] C. Benoist,et al. A multiplicity of CCAAT box-binding proteins , 1987, Cell.
[6] H. Thiesen,et al. Target Detection Assay (TDA): a versatile procedure to determine DNA binding sites as demonstrated on SP1 protein. , 1990, Nucleic acids research.
[7] P. Carlsson,et al. Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending. , 1994, The EMBO journal.
[8] K. Wright,et al. Major Histocompatibility Complex Class II-associated Invariant Chain Gene Expression Is Up-regulated by Cooperative Interactions of Sp1 and NF-Y (*) , 1995, The Journal of Biological Chemistry.
[9] S. Daniel,et al. Sp1 Mediates Glucose Activation of the Acetyl-CoA Carboxylase Promoter (*) , 1996, The Journal of Biological Chemistry.
[10] J. Nezu,et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. , 1998, Nature genetics.
[11] M. Stratton,et al. A serine/threonine kinase gene defective in Peutz–Jeghers syndrome , 1998, Nature.
[12] Y. Nishizuka,et al. Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] G. Suske. The Sp-family of transcription factors. , 1999, Gene.
[14] Geert J. P. L. Kops,et al. Direct control of the Forkhead transcription factor AFX by protein kinase B , 1999, Nature.
[15] D. Hardie,et al. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. , 1999, The Biochemical journal.
[16] M. Greenberg,et al. Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.
[17] R. Mantovani,et al. The molecular biology of the CCAAT-binding factor NF-Y. , 1999, Gene.
[18] G. Velasco,et al. FHX, a Novel Fork Head Factor with a Dual DNA Binding Specificity* , 2000, The Journal of Biological Chemistry.
[19] T. Nakazawa,et al. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. , 2000, The Biochemical journal.
[20] R. Medema,et al. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 , 2000, Nature.
[21] J. Herman,et al. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome , 2000, Oncogene.
[22] C. Martínez-A,et al. Forkhead transcription factors contribute to execution of the mitotic programme in mammals , 2001, Nature.
[23] Brian A. Hemmings,et al. Protein Kinase SGK Mediates Survival Signals by Phosphorylating the Forkhead Transcription Factor FKHRL1 (FOXO3a) , 2001, Molecular and Cellular Biology.
[24] M. Seldin,et al. Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. , 2002, Cancer research.
[25] David Sidransky,et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. , 2002, Cancer research.
[26] Jérôme Boudeau,et al. Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade , 2003, Journal of biology.
[27] H. T. Kang,et al. Down-regulation of Sp1 Activity through Modulation of O-Glycosylation by Treatment with a Low Glucose Mimetic, 2-Deoxyglucose* , 2003, Journal of Biological Chemistry.
[28] B. Kemp. Faculty Opinions recommendation of Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. , 2003 .
[29] R. DePinho,et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.
[30] Lewis C Cantley,et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[31] Hiroshi Handa,et al. NF-Y Is Essential for the Recruitment of RNA Polymerase II and Inducible Transcription of Several CCAAT Box-Containing Genes , 2005, Molecular and Cellular Biology.
[32] H. Hausen,et al. Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells* , 2005, Journal of Biological Chemistry.
[33] P. Propping,et al. High proportion of large genomic STK11 deletions in Peutz‐Jeghers syndrome , 2005, Human mutation.
[34] Kei Sakamoto,et al. LKB1-dependent signaling pathways. , 2006, Annual review of biochemistry.
[35] F. Colland,et al. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP , 2006, Nature Cell Biology.
[36] Wei Wu,et al. Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells. , 2006, Molecular endocrinology.
[37] William Stafford Noble,et al. Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays , 2006, Nature Methods.
[38] L. Aaltonen,et al. LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome , 2005, Journal of Medical Genetics.
[39] J. De-Castro Arce,et al. Retinoic Acid Receptor β Silences Human Papillomavirus-18 Oncogene Expression by Induction of de Novo Methylation and Heterochromatinization of the Viral Control Region* , 2007, Journal of Biological Chemistry.
[40] D. Saur,et al. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells. , 2007, Cancer research.
[41] D. Neil Hayes,et al. LKB1 modulates lung cancer differentiation and metastasis , 2007, Nature.
[42] S. Gygi,et al. The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor* , 2007, Journal of Biological Chemistry.
[43] J. De-Castro Arce,et al. Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1. , 2007, The Biochemical journal.
[44] B. Burgering,et al. Stressing the role of FoxO proteins in lifespan and disease , 2007, Nature Reviews Molecular Cell Biology.
[45] M. Pollak,et al. Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.
[46] V. Bhardwaj,et al. Tumour necrosis factor‐α attenuates insulin action on phosphoenolpyruvate carboxykinase gene expression and gluconeogenesis by altering the cellular localization of Foxa2 in HepG2 cells , 2009, The FEBS journal.
[47] M. Gerstein,et al. Unlocking the secrets of the genome , 2009, Nature.
[48] B. Lahn,et al. Systematic identification of cis-silenced genes by trans complementation , 2008, Human molecular genetics.
[49] W. Hahn,et al. SIK1 Couples LKB1 to p53-Dependent Anoikis and Suppresses Metastasis , 2009, Science Signaling.
[50] R. Shaw,et al. The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.
[51] Kwok-Kin Wong,et al. Somatic LKB1 Mutations Promote Cervical Cancer Progression , 2009, PloS one.
[52] D. Alessi,et al. The nuts and bolts of AGC protein kinases , 2010, Nature Reviews Molecular Cell Biology.